Retatrutide is a groundbreaking treatment generating substantial buzz in the obesity treatment field. This remarkable peptide, developed by researchers, functions as a double GIP and GLP-1 receptor agonist. Essentially, it replicates the action of these intrinsic hormones, which influence appetit